Rheonix Lands $21,862,496 New Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    22 Thornwood Drive Ithaca, NY 14850 USA
  • Company Description
    Rheonix, Inc. is exploiting its novel, patented, polymer chip microfluidic technology to introduce products that address some of the hottest issues in global healthcare today: Avian Influenza, HPV, TB, Dengue Fever, AIDS, SARS, bioterrorism, affordable healthcare in developing nations, personalized medicine, and molecular diagnostics, to name a few.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities or debt.
  • M&A Terms
  • Venture Investor

Trending on Xconomy